TScan Therapeutics, Inc. (TCRX) NASDAQ

1.80

-0.005(-0.28%)

Updated at August 18 02:42PM

Currency In USD

Valuation

Market Cap340.45M
Enterprise Value259.14M
P/E Ratio-1.72
PEG Ratio-0.02
Price/Sales Ratio26.37
Price/Book Ratio1.33
Enterprise/Revenue-0.66
Enterprise/EBITDA0.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-35.21
Operating Margin-37.13

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.64

Income Statement

Revenue2.82M
Revenue/Share0.03
Gross Profit2.82M
EBITDA-119.74M
Net Income-127.5M
Diluted EPS-1.14

Balance Sheet

Total Cash218.05M
Total Cash/Share1.68
Total Debt64.4M
Total Debt/Equity0.36
Current Ratio7.06
Book Value Per Share1.36

Price History

52-Week Change-69.83
52-Week High6.23
52-Week Low1.02
Moving Average 50 Days1.69
Moving Average 200 Days2.33

Statistics

Average Volume572,432
Shares Outstanding56.59M
% Held by Institutions27.53

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A